New era of electrochemotherapy in treatment of liver tumors in conjunction with immunotherapies

doi:10.3748/wjg.v27.i48.8216

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 27, Issue 48

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4633)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series.

Item

Count

PDF

289

WORD

175

HTML

2837

Figures (1-2)

374

Sum=3675

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

360

Download

598

Sum=958

Dec 28, 2021 (publication date) through Jan 11, 2025

Times Cited of This Article

Times Cited (16)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Frontier

World J Gastroenterol. Dec 28, 2021; 27(48): 8216-8226
Published online Dec 28, 2021. doi: 10.3748/wjg.v27.i48.8216

Open in New Tab Full Size Figure Download Figure

Figure 1 Electrochemotherapy using long needle electrodes in the percutaneous procedure. A: Positioning of the electrodes; B: Verification of the electrode positioning with computerized tomography; C: Treatment of the tumor, electric pulse delivery; D: Posttreatment.

Open in New Tab Full Size Figure Download Figure

Figure 2 Potential benefits of combining local ablative therapies with immune checkpoint inhibitors and anti-vascular therapies. IL-12: Interleukin-12.

Citation: Trotovšek B, Djokić M, Čemažar M, Serša G. New era of electrochemotherapy in treatment of liver tumors in conjunction with immunotherapies. World J Gastroenterol 2021; 27(48): 8216-8226
URL: https://www.wjgnet.com/1007-9327/full/v27/i48/8216.htm
DOI: https://dx.doi.org/10.3748/wjg.v27.i48.8216